Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS)
- Previous Close
39.78 - Open
39.81 - Bid 39.93 x --
- Ask 39.95 x --
- Day's Range
39.70 - 40.36 - 52 Week Range
39.48 - 66.80 - Volume
2,076,800 - Avg. Volume
2,405,236 - Market Cap (intraday)
6.125B - Beta (5Y Monthly) 0.79
- PE Ratio (TTM)
16.23 - EPS (TTM)
2.46 - Earnings Date --
- Forward Dividend & Yield 0.90 (2.26%)
- Ex-Dividend Date Apr 30, 2025
- 1y Target Est
--
Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells medicines in China. It offers medicines and pediatric drugs under the Jianmin, Longmu, and Yekaitai brand name. The company provides OTC, medical, and general health products, as well as consultation service. Jianmin Pharmaceutical Group Co.,Ltd. was founded in 1993 and is headquartered in Wuhan, China.
www.whjm.com2,345
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 600976.SS
View MorePerformance Overview: 600976.SS
Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 600976.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 600976.SS
View MoreValuation Measures
Market Cap
6.10B
Enterprise Value
5.05B
Trailing P/E
16.17
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.76
Price/Book (mrq)
2.40
Enterprise Value/Revenue
1.47
Enterprise Value/EBITDA
11.91
Financial Highlights
Profitability and Income Statement
Profit Margin
10.88%
Return on Assets (ttm)
2.15%
Return on Equity (ttm)
15.40%
Revenue (ttm)
3.43B
Net Income Avi to Common (ttm)
372.83M
Diluted EPS (ttm)
2.46
Balance Sheet and Cash Flow
Total Cash (mrq)
1.2B
Total Debt/Equity (mrq)
6.00%
Levered Free Cash Flow (ttm)
190.88M